Pereira-Fantini, PM,Lapthorne, S,Joyce, SA,Dellios, NL,Wilson, G,Fouhy, F,Thomas, SL,Scurr, M,Hill, C,Gahan, CGM,Cotter, PD,Fuller, PJ,Hardikar, W,Bines, JE

2014

November

Journal of hepatology

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease

Validated

Altmetric: 1 ()

Short bowel syndrome Liver diseases Intestinal failure associated liver disease Farnesoid X receptor NR1H4 Bile acids and salts Gut microbiota FARNESOID-X-RECEPTOR SMALL HETERODIMER PARTNER PARENTERAL-NUTRITION INTESTINAL FAILURE NUCLEAR RECEPTOR METABOLISM ACTIVATION MICROBIOTA EXPRESSION GENES

61

1115

1125

Background & Aims: Despite the mortality associated with liver disease observed in patients with short bowel syndrome (SBS), mechanisms underlying the development of SBS-associated liver disease (SBS-ALD) are poorly understood. This study examines the impact of bacterially-mediated bile acid (BA) dysmetabolism on farnesoid X receptor (FXR) signalling pathways and clinical outcome in a piglet model of SBS-ALD.Methods: 4-week old piglets underwent 75% small bowel resection (SBR) or sham operation. Liver histology and hepatic inflammatory gene expression were examined. Abundance of BA biotransforming bacteria was determined and metabolomic studies detailed the alterations in BA composition of stool, portal serum and bile samples. Gene expression of intestinal and hepatic FXR target genes and small heterodimer partner (SHP) transrepression targets were assessed.Results: Histological evidence of SBS-ALD included liver bile duct proliferation, hepatocyte ballooning and fibrosis. Inflammatory gene expression was increased. Microbiota changes included a 10-fold decrease in Clostridium and a two-fold decrease in Bacteroides in SBS-ALD piglets. BA composition was altered and reflected a primary BA dominant composition. Intestinal and hepatic regulation of BA synthesis was characterised by a blunted intestinal FXR activation response and a failure of SHP to repress key hepatic targets.Conclusions: We propose a pathological scenario in which microbial dysbiosis following SBR results in significant BA dysmetabolism and consequent outcomes including steatorrhoea, persistent diarrhoea and liver damage. Furthermore alterations in BA composition may have contributed to the observed disturbance in FXR-mediated signalling pathways. These findings provide an insight into the complex mechanisms mediating the development of liver disease in patients with SBS. Crown copyright (C) 2014 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver. All rights reserved.

10.1016/j.jhep.2014.06.025